Literature DB >> 8968716

BRCA1 R841W: a strong candidate for a common mutation with moderate phenotype.

D F Barker1, E R Almeida, G Casey, P R Fain, S Y Liao, I Masunaka, B Noble, T Kurosaki, H Anton-Culver.   

Abstract

BRCA1 mutations cause increased risk for breast and ovarian cancer, frequently of early onset. Many different mutations occur in BRCA1, including several examples of recurrent mutations, each of which accounts for a significant number of families with heritable cancer predisposition. These common mutations have an etiological role in many breast and ovarian cancer cases and provide the opportunity to examine genotype-phenotype correlations and genotype-environment interactions in individuals with the identical BRCA1 lesion. We report a novel missense change in BRCA1, 2640 C-->T (R841W), found in 3 cases from a subject group of 305 breast and 79 ovarian cancer cases from Orange County, CA. These are consecutive, population-based cases not selected for age or family history. In all three cases, there is a strong family history of breast, ovarian, or other cancers possibly related to a BRCA1 defect and family members showed a high concordance of cancer incidence with the presence of R841W. The age of cancer onset was not always distinct from typical sporadic cases. Testing of a sample of 413 unrelated individuals to examine the hypothesis that R841W might be a rare polymorphism detected one additional instance in a woman with breast cancer diagnosed at age 77 years, and cancer in one parent. R841W is likely to be an etiologically significant lesion with involvement in close to 1% (95% confidence interval of 0-1.7%) of all breast and ovarian cancers in this population.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8968716     DOI: 10.1002/(SICI)1098-2272(1996)13:6<595::AID-GEPI5>3.0.CO;2-#

Source DB:  PubMed          Journal:  Genet Epidemiol        ISSN: 0741-0395            Impact factor:   2.135


  10 in total

1.  Evidence for effective suppression of recombination in the chromosome 17q21 segment spanning RNU2-BRCA1.

Authors:  X Liu; D F Barker
Journal:  Am J Hum Genet       Date:  1999-05       Impact factor: 11.025

2.  A full-likelihood method for the evaluation of causality of sequence variants from family data.

Authors:  Deborah Thompson; Douglas F Easton; David E Goldgar
Journal:  Am J Hum Genet       Date:  2003-07-29       Impact factor: 11.025

3.  Integrated evaluation of DNA sequence variants of unknown clinical significance: application to BRCA1 and BRCA2.

Authors:  David E Goldgar; Douglas F Easton; Amie M Deffenbaugh; Alvaro N A Monteiro; Sean V Tavtigian; Fergus J Couch
Journal:  Am J Hum Genet       Date:  2004-08-02       Impact factor: 11.025

4.  Classification of Missense Mutations of Disease Genes.

Authors:  Xi Zhou; Edwin S Iversen; Giovanni Parmigiani
Journal:  J Am Stat Assoc       Date:  2005       Impact factor: 5.033

5.  Missense mutations in disease genes: a Bayesian approach to evaluate causality.

Authors:  G M Petersen; G Parmigiani; D Thomas
Journal:  Am J Hum Genet       Date:  1998-06       Impact factor: 11.025

6.  Characterization of BRCA1 and BRCA2 variants found in a Norwegian breast or ovarian cancer cohort.

Authors:  Elisabeth Jarhelle; Hilde Monica Frostad Riise Stensland; Lovise Mæhle; Marijke Van Ghelue
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

7.  Understanding missense mutations in the BRCA1 gene: an evolutionary approach.

Authors:  Melissa A Fleming; John D Potter; Christina J Ramirez; Gary K Ostrander; Elaine A Ostrander
Journal:  Proc Natl Acad Sci U S A       Date:  2003-01-16       Impact factor: 11.205

8.  Natural selection and mammalian BRCA1 sequences: elucidating functionally important sites relevant to breast cancer susceptibility in humans.

Authors:  Angela Burk-Herrick; Mark Scally; Heather Amrine-Madsen; Michael J Stanhope; Mark S Springer
Journal:  Mamm Genome       Date:  2006-03-03       Impact factor: 2.957

9.  Mutations of the BRCA1 and BRCA2 genes in patients with bilateral breast cancer.

Authors:  D Steinmann; M Bremer; D Rades; B Skawran; C Siebrands; J H Karstens; T Dörk
Journal:  Br J Cancer       Date:  2001-09-14       Impact factor: 7.640

10.  BRCA1 mutations in southern England.

Authors:  D M Eccles; P Englefield; M A Soulby; I G Campbell
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.